A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function

Journal of Bacteriology

Volumn 181, Issue 2, 1999, Pages 444-453

  Thompson, John R ^a   Douglas, Cameron M ^a   Li, Weili ^a   Jue, Chong K ^a,c   Pramanik, Barnali ^a   Yuan, Xiling ^a   Rude, Thomas H ^b   Toffaletti, Dena L ^b   Perfect, John R ^b   Kurtz, Myra ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; CHITIN; ECHINOCANDIN B; FUNGAL DNA; GLUCAN; GLUCAN SYNTHASE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL VIABILITY; CELL WALL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DNA SEQUENCE; FUNGAL MENINGITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY;

ASPERGILLUS; CANDIDA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0032925368     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.181.2.444-453.1999     Document Type: Article

References (61)

1. Bartizal, K., G. Abruzzo, C. Trainor, D. Krupa, K. Nollstadt, D. Schmatz, R. Schwartz, M. Hammond, J. Balkovec, and F. Vanmiddlesworth. 1992. In vitro antifungal activities and in vivo efficacies of 1,3-β-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin. Antimicrob. Agents Chemother. 36:1648-1657.
2. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332.
3. Bastide, J. M., E. H. Hadibi, and M. Bastide. 1979. Taxonomic significance of yeast sphaeroplast release after enzymatic treatment of intact cells. J. Gen. Microbiol. 113:147-153.
4. Berg, J., C. J. Clancy, and M. H. Nguyen. 1998. The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin. Infect. Dis. 26: 186-187.
5. o derivatives. J. Med. Chem. 37:222-225.
6. Cabib, E., B. Bowers, A. Sburlati, and S. J. Silverman. 1988. Fungal cell wall synthesis: the construction of a biological structure. Microbiol. Sci. 5:370-375.
7. Castro, C., J. C. Ribas, M. H. Valdivieso, R. Varona, F. del Rey, and A. Duran. 1995. Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)β-D-glucan synthesis in Saccharomyces cerevisiae. J. Bacteriol. 177:5732-5739.
8. Debono, M., and R. S. Gordee. 1994. Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol. 48:471-497.
9. Del Poeta, M., W. A. Schell, and J. R. Perfect. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836.
10. Del Poeta, M., D. L. Toffaletti, T. H. Rude, C. C. Dykstra, J. Heitman, and J. R. Perfect. The role of the Cryptococcus neoformans topoisomerase I gene in pathobiology and as an antifungal target. Submitted for publication.
11. Douglas, C. M., J. A. D'Ippolito, G. J. Shei, M. Meinz, J. Onishi, J. A. Marrinan, W. Li, G. K. Abruzzo, A. Flattery, K. Bartizal, A. Mitchell, and M. B. Kurtz. 1997. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-β-D-glucan synthase inhibitors. Antimicrob. Agents Chemother. 41:2471-2479.
12. Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahl, P. Mazur, W. Baginsky, W. Li, M. El-Sherbeini, J. A. Clemas, S. M. Mandala, F. R. Frommer, and M. B. Kurtz. 1994. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-β-D-glucan synthase. Proc. Natl. Acad. Sci. USA 91:12907-12911.
13. Douglas, C. M. Personal communication.
14. Douglas, C. M., S. A. Parent, W. Li, G. Chrebet, J. A. Marrinan, and M. B. Kurtz. Mutations in Saccharomyces cerevisiae FKS genes identify residues critical for function and susceptibility to glucan synthase inhibitors. Submitted for publication.
15. Drgonova, J., T. Drgon, K. Tanaka, R. Kollar, G. C. Chen, R. A. Ford, C. Chan, Y. Takai, and E. Cabib. 1996. Rho 1p, a yeast protein at the interface between cell polarization and morphogenesis. Science 272:277-279.
16. Edman, J. C., and K. J. Kwon Chung. 1990. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 10:4538-4544.
17. Fleet, G. H. 1985. Composition and structure of yeast cell walls. Curr. Top. Med. Mycol. 1:24-56.
18. Georgopapadakou, N. H., and J. S. Tkacz. 1995. The fungal cell wall as a drug target. Trends Microbiol. 3:98-104.
19. Gozalbo, D., M. V. Elorza, R. Sanjuan, A. Marcilla, E. Valentin, and R. Sentandreu. 1993. Critical steps in fungal cell wall synthesis: strategies for their inhibition. Pharmacol. Ther. 60:337-345.
20. Grunstein, M., and D. S. Hogness. 1975. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc. Natl. Acad. Sci. USA 72:3961-3965.
21. + , a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B. J. Bacteriol. 179:7653-7662.
22. Iwata, K., Y. Yamamoto, H. Yamaguchi, and T. Hiratani. 1982. In vitro studies of aculeacin A, a new antifungal antibiotic. J. Antibiot. 35:203-209.
23. Joseph-Horne, T., D. Hollomon, R. S. Loeffler, and S. L. Kelly. 1995. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob. Agents Chemother. 39:1526-1529.
24. Kauffman, C. A., and P. L. Carver. 1997. Antifungal agents in the 1990s. Current status and future developments. Drugs 53:539-549.
25. Kelly, R., E. Register, M. J. Hsu, M. Kurtz, and J. Nielsen. 1996. Isolation of a gene involved in 1,3-β-D-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein. J. Bacteriol. 178:4381-4391.
26. Kohno, H., K. Tanaka, A. Mino, M. Umikawa, H. Imamura, T. Fujiwara, Y. Fujita, K. Hotta, H. Qadota, T. Watanabe, Y. Ohya, and Y. Takai. 1996. Bni1p implicated in cytoskeletal control is a putative target of Rho1p small GTP binding protein in Saccharomyces cerevisiae. EMBO J. 15:6060-6068.
27. Krishnarao, T. V., and J. N. Galgiani. 1997. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:1957-1960.
28. Lamb, D. C., A. Corran, B. C. Baldwin, J. Kwon-Chung, and S. L. Kelly. 1995. Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients. FEBS Lett. 368:326-330.
29. Lodge, J. K., E. Jackson Machelski, D. L. Toffaletti, J. R. Perfect, and J. I. Gordon. 1994. Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 91:12008-12012.
30. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
31. Mazur, P., and W. Baginsky. 1996. In vitro activity of the 1,3-β-D-glucan synthase requires the GTP-binding protein Rho1. J. Biol. Chem. 211:14604-14609.
32. Mazur, P., N. Morin, W. Baginsky, M. el Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15: 5671-5681.
33. McClelland, M., J. Hanish, M. Nelson, and Y. Patel. 1988 KGB: a single buffer for all restriction endonucleases. Nucleic Acids Res. 16:364.
34. Mio, T., M. Adachi Shimizu, Y. Tachibana, H. Tabuchi, S. B. Inoue, T. Yabe, T. Yamada Okabe, M. Arisawa, T. Watanabe, and H. Yamada Okabe. 1997. Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/ FKS1 and its involvement in 1,3-β-D-glucan synthesis. J. Bacteriol. 179:4096-4105.
35. Miyata, M., J. Kitamura, and H. Miyata. 1980. Lysis of growing fission-yeast cells induced by aculeacin A, a new antifungal antibiotic. Arch. Microbiol. 127:11-16.
36. Nicholas, R., D. Williams, and P. Hunter. 1994. Investigation of the value of β-glucan-specific flourochromes for predicting the β-glucan content of cell walls of zoopathogenic fungi. Mycol. Res. 98:694-698.
37. Nonaka, H., K. Tanaka, H. Hirano, T. Fujiwara, H. Kohno, M. Umikawa, A. Mino, and Y. Takai. 1995. A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae. EMBO J. 14:5931-5938.
38. Osumi, M., N. Yamada, H. Kobori, A. Taki, N. Naito, M. Baba, and T. Nagatani. 1989. Cell wall formation in regenerating protoplasts of Schizosaccharomyces pombe: study by high resolution, low voltage scanning electron microscopy. J. Electron Microsc. 38:457-468.
39. Page, R. D. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
40. Payne, T., and R. Calderone. 1997. Characterization of the phosphoribosylpyrophosphate synthetase gene from Candida albicans. J. Med. Vet. Mycol. 35:305-312.
41. Perfect, J. R., S. D. Lang, and D. T. Durack. 1980. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol. 101:177-194.
42. Petter, R., Y. C. Chang, and K. J. Kwon-Chung. 1997. A gene homologous to Saccharomyces cerevisiae SNF1 appears to be essential for the viability of Candida albicans. Infect. Immun. 65:4909-4917.
43. Pfaller, M. A., S. A. Messer, and S. Coffman. 1997. In vitro susceptibilities of 435 clinical yeast isolates to a new echinocandin derivative. LY303366, and other antifungal agents. Antimicrob. Agents Chemother. 41:763-766.
44. Qadota, H., I. Ishii, A. Fujiyama, Y. Ohya, and Y. Anraku. 1992. RHO gene products, putative small GTP-binding proteins, are important for activation of the CAL1/CDC43 gene product, a protein geranylgeranyltransferase in Saccharomyces cerevisiae. Yeast 8:735-741.
45. Qadota, H., C. P. Python, S. B. Inoue, M. Arisawa, Y. Anraku, Y. Zheng, T. Watanabe, D. E. Levin, and Y. Ohya. 1996. Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-β-D-glucan synthase. Science 272:279-281.
46. Radding, J. A., S. A. Heidler, and W. W. Turner. 1998. Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans. Antimicrob. Agents Chemother. 42:1187-1194.
47. Ram, A. Personal communication.
48. Ribas, J. C., C. Roncero, H. Rico, and A. Duran. 1991. Characterization of a Schizosaccharomyces pombe morphological mutant altered in the galactomannan content. FEMS Microbiol. Lett. 63:263-267.
49. Ruiz Herrera, J. 1991. Biosynthesis of beta-glucans in fungi. Antonie Leeuwenhoek 60:72-81.
50. Sable, C. 1997. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 28 September to 1 October 1997.
51. Sherman, F., G. Fink, and J. Hicks. 1983. Methods in yeast genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
52. Sipos, L., and G. von Heijne. 1993. Predicting the topology of eukaryotic membrane proteins. Eur. J. Biochem. 213:1333-1340.
53. Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595-596.
54. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
55. Toffaletti, D. L., T. H. Rude, S. A. Johnston, D. T. Durack, and J. R. Perfect. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.
56. Varma, A., J. C. Edman, and K. J. Kwon Chung. 1992. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect. Immun. 60:1101-1108.
57. Varma, A., and K. J. Kwon Chung. 1991. Rapid method to extract DNA from Cryptococcus neoformans. J. Clin. Microbiol. 29:810-812.
58. Venkateswarlu, K., M. Taylor, N. J. Manning, M. G. Rinaldi, and S. L. Kelly. 1997. Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:748-751.
59. Wery, J., M. J. Dalderup, J. Ter Linde, T. Boekhout, and A. J. Van Ooyen. 1996. Structural and phylogenetic analysis of the actin gene from the yeast Phaffia rhodozyma. Yeast. 12:641-651.
60. Williamson, J. Personal communication.
61. Yamochi, W., K. Tanaka, H. Nonaka, A. Maeda, T. Musha, and Y. Takai. 1994. Growth site localization of Rho1 small GTP-binding protein and its involvement in bud formation in Saccharomyces cerevisiae. J. Cell Biol. 125: 1077-1093.